-
Mashup Score: 0Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO - 2 year(s) ago
Investigators from the TRANSITION-T2D study join Diabetes Dialogue to discuss the study and implications for care.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD - 2 year(s) ago
W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over the growing prevalence of online weight loss clinics
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Need to catch up on all the #obesity news from #ADA2023? Hear from Dr. Garvey as he discusses SURMOUNT-2 and more in the latest #DiabetesDialogue: https://t.co/DzifsvoSpp
-
-
Mashup Score: 1Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD - 2 year(s) ago
W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over the growing prevalence of online weight loss clinics
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The latest #DiabetesDialogue from #ADA2023 is now live! Dr. Garvey breaks down SURMOUNT-2 and his perspective on other topics, such as his concern over online #obesity clinics and compounded versions of semaglutide. https://t.co/kWZPvcT99a @DianaMIsaacs @natalie_bellini https://t.co/B8eUuoun0w
-
-
Mashup Score: 0
In this episode, hosts sit down for an in-depth discussion of the 11 person-centered algorithms for clinical decision-making featured in the AACE’s 2023 Comprehensive Type 2 Diabetes Management Algorithm.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Need a breakdown on the AACE 2023 T2D Management Algorithms? Check out the latest episode of #DiabetesDialogue! https://t.co/T8C0kUgDQ9 #Diabetes https://t.co/DhJCHT2kHD
-
-
Mashup Score: 0
In this episode, hosts sit down for an in-depth discussion of the 11 person-centered algorithms for clinical decision-making featured in the AACE’s 2023 Comprehensive Type 2 Diabetes Management Algorithm.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Have you checked out @TheAACE new #T2D treatment algorithms? Catch up on what you may have missed in the latest #DiabetesDialogue: https://t.co/T8C0kUgDQ9 https://t.co/2iifOYpI3E
-
-
Mashup Score: 5
In this episode, hosts sit down for an in-depth discussion of the 11 person-centered algorithms for clinical decision-making featured in the AACE’s 2023 Comprehensive Type 2 Diabetes Management Algorithm.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The latest episode of #DiabetesDialogue is now live! Catch our hosts @DianaMIsaacs and @natalie_bellini break down @TheAACE's new treatment algorithms for management of #Type2Diabetes. https://t.co/T8C0kUgDQ9 #Diabetes https://t.co/G5CPDk9hw4
-
-
Mashup Score: 0Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD - 2 year(s) ago
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use, exclusive features, and how patients can obtain the new system.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The latest episode of #DiabetesDialogue is now live! Hosts @DianaMIsaacs and @natalie_bellini sit down with Dr. Vigersky of @Medtronic to discuss the approval of the MiniMed 780G system: https://t.co/fVuARodSGV https://t.co/NfDsX7epw3
-
-
Mashup Score: 0Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD - 2 year(s) ago
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use, exclusive features, and how patients can obtain the new system.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
What does the approval of the MiniMed 780G system mean for people with #Type1Diabetes? In this episode of #DiabetesDialogue, our hosts sat down with the CMO of @MDT_Diabetes to get the answer to that question and more! Use the link below to learn more: https://t.co/6MuSSD5aaW https://t.co/71H2vKb2U2
-
-
Mashup Score: 0
In this episode, hosts offer their reaction to topline data from the SURMOUNT-2 trial examining tirzepatide for weight management in T2D, the FDA’s clearance of the Omnipod GO device, and results of the CLVer trial.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The latest episode of #DiabetesDialogue is now live! Tune in for the hosts' reactions to SURMOUNT-2 data, Omnipod GO's FDA clearance, and data from the CLVer trial. https://t.co/mCD2T6vzCa #Diabetes #Obesity https://t.co/ObvS4kP8Bo
-
-
Mashup Score: 0FDA Clears Reader for Abbott FreeStyle Libre 3 System - 2 year(s) ago
Announced on April 14, the clearance allows for FreeStyle Libre 3 users to obtain real-time glucose readings on a large, easy-to-see screen directly from their back of arm sensors.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Earlier this month, @AbbottNews announced #FDA marketing clearance of readers for their FreeStyle Libre 3 iCGM system. Learn more about how this paves the way for possible CMS coverage in the latest #DiabetesDialogue https://t.co/SiydOznofs https://t.co/v4669fnGbD
-
Another episode of #DiabetesDialogue from #ADA2023 is now live! Drs. @DianaMIsaacs and @natalie_bellini are joined by Drs. Rodriguez and Pantalone to discuss the @ClevelandClinic's TRANSITION-T2D study. https://t.co/6CCyfLSkgO #Diabetes https://t.co/HCW13BPl5g